Hua Liu

Title: Hua Liu - Innovator in Biotherapeutics

Introduction

Hua Liu is a prominent inventor based in Shoreline, WA (US). He has made significant contributions to the field of biotherapeutics, particularly in the development of fusion proteins and bispecific antibodies. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Hua Liu holds a patent for "Heterodimeric Fc for making fusion proteins and bispecific antibodies." This patent includes variant-Fc-region fusion proteins, variant-Fc-region-antibodies, and heterodimeric-variant-Fc-region-bispecific-antibodies. The invention also encompasses nucleic acids encoding these proteins, host cells containing such nucleic acids, and methods of treatment utilizing these innovative biotherapeutics. The patent highlights methods for producing these proteins in host cells, showcasing Liu's commitment to enhancing therapeutic options.

Career Highlights

Hua Liu is associated with Qilu Puget Sound Biotherapeutics Corporation, where he continues to push the boundaries of biotherapeutic research. His work is characterized by a focus on creating effective treatments that leverage the power of fusion proteins and antibodies. Liu's contributions are vital in the ongoing quest for innovative solutions in healthcare.

Collaborations

Hua Liu collaborates with notable colleagues, including Zhi Liu and Victor Hermand. These partnerships enhance the research environment and foster the development of groundbreaking biotherapeutic solutions.

Conclusion

Hua Liu's innovative work in the field of biotherapeutics, particularly through his patent on heterodimeric Fc proteins, exemplifies his commitment to advancing medical science. His contributions are paving the way for new treatment methodologies that could significantly impact patient care.